Dr. Lingtao Jin's lab focuses on developing new therapeutic strategies for hard-to-treat cancers, particularly ovarian cancer and non-small cell lung cancer (NSCLC). The lab investigates how specific proteins influence cancer cell survival and drug resistance, aiming to create more effective treatments through innovative approaches like PROTACs and targeting glycosylation pathways. Their research could lead to improved responses to existing cancer therapies.